company

BioLineRx, Ltd.

as of 2026-07-01
at a glance
4 trials sponsored · 6 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

6 assets

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Risperidone
small molecule
drug
BL - 1020
small molecule
drug
BL 1020 High Dose
small molecule
drug
BL-1020
small molecule
drug
BL-1020 10-30 mg
small molecule
drug
CYP-1020
small molecule
drug